{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:10Z","timestamp":1791474670897,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.taap.2022.116328","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T21:57:40Z","timestamp":1669672660000},"page":"116328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Drug repurposing of ilepcimide that ameliorates experimental autoimmune encephalomyelitis via restricting inflammatory response and oxidative stress"],"prefix":"10.1016","volume":"458","author":[{"given":"Zhaomin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2022.116328_bb0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrneurol.2016.59","article-title":"Advanced MRI and staging of multiple sclerosis lesions","volume":"12","author":"Absinta","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.taap.2022.116328_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33594\/000000117","article-title":"Oxidative stress induces expression of the toll-like receptors (TLRs) 2 and 4 in the human peripheral blood mononuclear cells: implications for metabolic inflammation","volume":"53","author":"Akhter","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.taap.2022.116328_bb0015","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.4049\/jimmunol.1400401","article-title":"Neutrophils mediate blood-spinal cord barrier disruption in demyelinating Neuroinflammatory diseases","volume":"193","author":"Aub\u00e9","year":"2014","journal-title":"J.Immunol."},{"key":"10.1016\/j.taap.2022.116328_bb0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2018.10.014","article-title":"Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells","volume":"29","author":"Bajzikova","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2022.116328_bb0025","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1169920","article-title":"Drug discovery. Repurposing with a difference","volume":"324","author":"Boguski","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.taap.2022.116328_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arr.2017.10.005","article-title":"The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE)","volume":"41","author":"Bolton","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.taap.2022.116328_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd.2018.92","article-title":"Overcoming the legal and regulatory barriers to drug repurposing","volume":"18","author":"Breckenridge","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116328_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116328_bb0045","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2022.116328_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","article-title":"Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"157","author":"Buendia","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2022.116328_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jnnp-2011-300414","article-title":"Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study","volume":"83","author":"Calabrese","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.taap.2022.116328_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101689","article-title":"Isomeric O-methyl cannabidiolquinones with dual BACH1\/NRF2 activity","volume":"37","author":"Casares","year":"2020","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.taap.2022.116328_bib353","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.27358","article-title":"Birth outcomes in women who have taken leflunomide during pregnancy","volume":"62","author":"Chambers","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2022.116328_bb0065","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cmet.2018.05.006","article-title":"Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota","volume":"27","author":"Cignarella","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2022.116328_bb0070","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2022.116328_bb0075","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116328_bb0080","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1021\/jm001003p","article-title":"Synthesis and immunosuppressive activity of novel prodigiosin derivatives","volume":"43","author":"D\u2019Alessio","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2022.116328_bb0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/emmm.201202124","article-title":"A TSPO ligand is protective in a mouse model of multiple sclerosis","volume":"5","author":"Daugherty","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.taap.2022.116328_bb0090","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/14728222.2013.815726","article-title":"CD8(+) T cells in multiple sclerosis","volume":"17","author":"Denic","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.taap.2022.116328_bb0095","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1021\/jm300630p","article-title":"Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening","volume":"55","author":"Diao","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2022.116328_bb0100","first-page":"237","article-title":"The use of concanavalin a to study the immunoregulation of human T cells","volume":"46","author":"Dwyer","year":"1981","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.taap.2022.116328_bb0105","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1021\/ci400040d","article-title":"Docking challenge: protein sampling and molecular docking performance","volume":"53","author":"Elokely","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2022.116328_bb0110","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41467-017-02119-6","article-title":"Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic","volume":"8","author":"Faissner","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.taap.2022.116328_bb0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/BSR20120046","article-title":"Protein instability and functional defects caused by mutations of Dihydro-Orotate dehydrogenase in Miller syndrome patients[J]","volume":"32","author":"Fang","year":"2012","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.taap.2022.116328_bib352","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s40263-013-0118-2","article-title":"Teriflunomide: a review of its use in relapsing multiple sclerosis","volume":"27","author":"Garnock-Jones","year":"2013","journal-title":"CNS Drugs."},{"key":"10.1016\/j.taap.2022.116328_bb0120","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2022.116328_bb0125","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16495.1","article-title":"Emerging small-molecule treatments for multiple sclerosis: focus on B cells","volume":"8","author":"Gregson","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.taap.2022.116328_bib354","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2147\/DDDT.S137572","article-title":"Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis","volume":"11","author":"Guarnera","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.taap.2022.116328_bb0135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/11310900-000000000-00000","article-title":"Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management","volume":"23","author":"Kelley","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.taap.2022.116328_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5563","article-title":"Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects","volume":"11","author":"Klotz","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2022.116328_bb0145","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1528-1167.2008.01565.x","article-title":"Seizures in multiple sclerosis","volume":"49","author":"Koch","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2022.116328_bb0155","doi-asserted-by":"crossref","first-page":"eaaw7852","DOI":"10.1126\/scitranslmed.aaw7852","article-title":"Identification of DHODH as a therapeutic target in small cell lung cancer","volume":"11","author":"Li","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2022.116328_bb0160","doi-asserted-by":"crossref","first-page":"14836","DOI":"10.1038\/srep14836","article-title":"Rational design of benzylidenehydrazinyl-substituted thiazole derivatives as potent inhibitors of human dihydroorotate dehydrogenase with in vivo anti-arthritic activity","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2022.116328_bb0165","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1016\/0006-2952(84)90055-8","article-title":"Stimulation of serotonin synthesis in rat brain after antiepilepsirine, an antiepileptic piperine derivative","volume":"33","author":"Liu","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2022.116328_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0969-2126(00)00077-0","article-title":"Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents","volume":"8","author":"Liu","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.taap.2022.116328_bb0175","first-page":"177","article-title":"Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase","author":"Liu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2022.116328_bb0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ni.3389","article-title":"T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis","volume":"17","author":"Martin","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2022.116328_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172973","article-title":"Targeting Keap1\/Nrf2\/ARE signaling pathway in multiple sclerosis","volume":"873","author":"Michali\u010dkov\u00e1","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2022.116328_bb0190","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd3473","article-title":"Could pharma open its drug freezers?","volume":"10","author":"Mullard","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116328_bb0195","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrd3776","article-title":"Drug repurposing programmes get lift off","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116328_bb0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.taap.2022.116328_bb0220","first-page":"455","article-title":"Scientific advice - is drug repurposing missing a trick? Nature reviews","volume":"14","author":"Pantziarka","year":"2017","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.taap.2022.116328_bb0225","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1021\/jm010822m","article-title":"Aromatic Quinolinecarboxamides as selective, orally active antibody production inhibitors for prevention of acute xenograft rejection","volume":"44","author":"Papageorgiou","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2022.116328_bb0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1157.1983.tb04877.x","article-title":"A review of pharmacology and clinical use of piperine and its derivatives","volume":"24","author":"Pei","year":"1983","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2022.116328_bb0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/187152610791163336","article-title":"Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy","volume":"10","author":"Phillips","year":"2010","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.taap.2022.116328_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2022.116328_bb0245","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/nn.3168","article-title":"Animal models of multiple sclerosis: the good, the bad and the bottom line","volume":"15","author":"Ransohoff","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.taap.2022.116328_bb0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2022.116328_bb0255","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","article-title":"The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment","volume":"122","author":"Robinson","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.taap.2022.116328_bb0260","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.15252\/emmm.201404168","article-title":"R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice","volume":"6","author":"Schmitz","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.taap.2022.116328_bb0265","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ccell.2022.07.011","article-title":"De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.taap.2022.116328_bb0270","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2016.09.085","article-title":"Dihydroorotate dehydrogenase: a drug target for the development of antimalarials","volume":"125","author":"Singh","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2022.116328_bb0275","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2019.03.045","article-title":"Mitochondrial regulation of the hippocampal firing rate set point and seizure susceptibility","volume":"102","author":"Styr","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2022.116328_bb0285","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/jim-2016-000339","article-title":"Update on disease-modifying therapies for multiple sclerosis","volume":"65","author":"Vargas","year":"2017","journal-title":"J. Investig. Med.: Off. Publ. Am. Feder. Clin. Res."},{"key":"10.1016\/j.taap.2022.116328_bb0295","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1523\/JNEUROSCI.2698-10.2011","article-title":"Longitudinal near-infrared imaging of myelination","volume":"31","author":"Wang","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2022.116328_bb0305","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0387-7604(98)00066-7","article-title":"Trial of antiepilepsirine (AES) in children with epilepsy","volume":"21","author":"Wang","year":"1999","journal-title":"Brain and Development"},{"key":"10.1016\/j.taap.2022.116328_bb0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0387-7604(98)00066-7","article-title":"Trial of antiepilepsirine (AES) in children with epilepsy","volume":"21","author":"Wang","year":"1999","journal-title":"Brain and Development"},{"key":"10.1016\/j.taap.2022.116328_bb0320","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yebeh.2015.04.050","article-title":"Review of the use of botanicals for epilepsy in complementary medical systems--Traditional Chinese Medicine","volume":"52","author":"Xiao","year":"2015","journal-title":"Epilep. Behav.: E&B"},{"key":"10.1016\/j.taap.2022.116328_bb0335","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0022-3565(25)11088-4","article-title":"Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats","volume":"261","author":"Yan","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2022.116328_bb0340","doi-asserted-by":"crossref","first-page":"40670","DOI":"10.1038\/srep40670","article-title":"Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker","volume":"7","author":"Yin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2022.116328_bib351","article-title":"Bu shen yi sui capsule alleviates neuroinflammation and demyelination by promoting microglia toward M2 polarization, which correlates with changes in miR-124 and miR-155 in experimental autoimmune encephalomyelitis","volume":"5521503","author":"Zha","year":"2021","journal-title":"Oxid Med Cell Longev."},{"key":"10.1016\/j.taap.2022.116328_bb0345","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s11427-019-9587-y","article-title":"Nature brings new avenues to the therapy of central nervous system diseases-an overview of possible treatments derived from natural products","volume":"62","author":"Zhang","year":"2019","journal-title":"Sci. China Life Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22004732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22004732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:00:49Z","timestamp":1758574849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X22004732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":62,"alternative-id":["S0041008X22004732"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2022.116328","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing of ilepcimide that ameliorates experimental autoimmune encephalomyelitis via restricting inflammatory response and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2022.116328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116328"}}